Quarterly Results • Search Archive
Jubilant Ingrevia Limited
Results, Financials & Updates
Follow Jubilant Ingrevia Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
2 published deep dives
2 quarters 2 sectors
Company Overview
Jubilant Ingrevia Limited: latest results and financials
About the business in Nivata's latest coverage
Jubilant Ingrevia Limited is a global player in specialty chemicals and custom development and manufacturing (CDMO), serving pharmaceutical, nutrition, agrochemical, consumer, semiconductor, and industrial customers. The company operates across three business segments: Specialty Chemicals (encompassing Pyridine, Picolines, Fine Chemicals, and CDMO), Nutrition & Health Solutions (animal and human nutrition products including Vitamin B3, Choline, and premixes), and Chemical Intermediates (including Acetic Anhydride and Ethyl Acetate).
Quarter History
Jubilant Ingrevia reported trend
Each row comes from the corresponding Nivata Results brief. Reporting scope can differ between quarters; open the quarter for full context.
Quarter history
Jubilant Ingrevia Limited Results & Financials
Latest Nivata coverage: Q2 FY27 · revenue ₹1,381.15 Cr · PAT ₹111.43 Cr.
MainboardQ2 FY27
Jubilant Ingrevia Limited
ChemicalsNSE: JUBLINGREA · Consolidated
Sales growth (YoY)+24.5% Profit growth (YoY)+60.4%
Read the results deep dive ↗
MainboardQ1 FY27
Jubilant Ingrevia Limited
HealthcareNSE: JUBLINGREA · Consolidated
Revenue from operations · current quarter₹1,300.27 CrReported Q1 FY27 Profit after tax · current quarter₹105.82 CrReported Q1 FY27
Read the results deep dive ↗